PhorMed

Join Us in the Fight to Cure Cancer! Pre-Public Limited Time Offer *10% Bonus Discount*

https://wefunder.com/phormed

Total raised on Wefunder: 204025

Total investors: 228

Quick facts

  • In a clinical study, we helped 83% of patients beat cancer
  • Our drug repairs damaged cells and kills cancer
  • On a mission to bring new hope and a brighter future to patients battling life-threatening diseases
  • $3.5 million raised from >4,100 investors: Crowdfunding and Angel investors
  • Undervalued position, potential to buy low/sell high. PhorMed = $53M; Similar Companies = $290M-1.2B
  • FDA allowing “FAST-TRACKING” clinical studies = huge time & cost savings
  • Our team has 533 peer-reviewed publications
  • Company is ready to start three phase 2 studies

Team profiles

Featured investor profiles

PhorMed

Join Us in the Fight to Cure Cancer! Pre-Public Limited Time Offer *10% Bonus Discount*

What Investors Say

LEAD INVESTOR
Invested $10,000 this round + $10,000 previously
I invested in PhorMed because, being in the medical field myself, I believe the technology to be exciting and groundbreaking. The drug being developed has great potential to help save lives while increasing the quality of life to many who do not currently have treatment options.   I also like that the company’s technology was fast tracked by the FDA. Seems the company has provided ample clinical support for the FDA to help move trials forward in a more rapid pace which is also a huge overall cost savings to the company
What People Say